{"id":"NCT00267670","sponsor":"Northwestern University","briefTitle":"Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH","officialTitle":"The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2005-03","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2005-12-21","resultsPosted":"2014-09-09","lastUpdate":"2014-09-09"},"enrollment":26,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Nonalcoholic Steatohepatitis","Liver Diseases"],"interventions":[{"type":"DRUG","name":"Pentoxifylline","otherNames":["Trental"]},{"type":"DRUG","name":"Placebo","otherNames":["sugar pill"]}],"arms":[{"label":"Pentoxifylline","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to explore the potential benefit of the medication, pentoxifylline, for the treatment of NASH.","primaryOutcome":{"measure":"The Number of Participants With a 30% Reduction in Alanine Aminotransferase (ALT) Treated With Pentoxifylline (PTX) or Placebo for 12 Months.","timeFrame":"baseline and 12 months","effectByArm":[{"arm":"Pentoxifylline","deltaMin":19,"sd":null},{"arm":"Placebo","deltaMin":7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.46"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21677329"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":19},"commonTop":[]}}